Growth hormone response to growth hormone-releasing factor in depression

K. Ranga R Krishnan, Ananth N. Manepalli, James C. Ritchie, Krishniah Rayasam, Mary Lou Melville, Michael O. Thorner, Jean E. Rivier, Wylie W. Vale, Charles Nemeroff

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A blunted growth hormone (GH) response to clonidine and other pharmacologic stimuli has been reported in patients with depression. This blunted growth hormone response to clonidine had led to the speculation that there is a central alpha-2 adrenergic receptor subsensitivity in depression. This hypothesis is based on the assumption that the pituitary somatotroph response to growth hormone-releasing factor (GHRF) is not altered in depression. In the present preliminary study, the somatotroph response to GHRF in depressed patients and normal controls has been evaluated in four depressed patients and four age- and sex-matched controls. The GH response to GRF is highly variable both in normal individuals and in the depressed patients studied. Larger numbers of patients and controls must be studied before any definitive conclusions can be drawn about GH responses to GRF in depressed patients.

Original languageEnglish
Pages (from-to)113-116
Number of pages4
JournalPeptides
Volume9
Issue numberSUPPL. 1
DOIs
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Growth Hormone-Releasing Hormone
Growth Hormone
Clonidine
Somatotrophs
Adrenergic alpha-2 Receptors

Keywords

  • Depression
  • Growth hormone (GH)
  • Growth hormone-releasing factor (GHRF)

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Krishnan, K. R. R., Manepalli, A. N., Ritchie, J. C., Rayasam, K., Melville, M. L., Thorner, M. O., ... Nemeroff, C. (1988). Growth hormone response to growth hormone-releasing factor in depression. Peptides, 9(SUPPL. 1), 113-116. https://doi.org/10.1016/0196-9781(88)90234-3

Growth hormone response to growth hormone-releasing factor in depression. / Krishnan, K. Ranga R; Manepalli, Ananth N.; Ritchie, James C.; Rayasam, Krishniah; Melville, Mary Lou; Thorner, Michael O.; Rivier, Jean E.; Vale, Wylie W.; Nemeroff, Charles.

In: Peptides, Vol. 9, No. SUPPL. 1, 01.01.1988, p. 113-116.

Research output: Contribution to journalArticle

Krishnan, KRR, Manepalli, AN, Ritchie, JC, Rayasam, K, Melville, ML, Thorner, MO, Rivier, JE, Vale, WW & Nemeroff, C 1988, 'Growth hormone response to growth hormone-releasing factor in depression', Peptides, vol. 9, no. SUPPL. 1, pp. 113-116. https://doi.org/10.1016/0196-9781(88)90234-3
Krishnan KRR, Manepalli AN, Ritchie JC, Rayasam K, Melville ML, Thorner MO et al. Growth hormone response to growth hormone-releasing factor in depression. Peptides. 1988 Jan 1;9(SUPPL. 1):113-116. https://doi.org/10.1016/0196-9781(88)90234-3
Krishnan, K. Ranga R ; Manepalli, Ananth N. ; Ritchie, James C. ; Rayasam, Krishniah ; Melville, Mary Lou ; Thorner, Michael O. ; Rivier, Jean E. ; Vale, Wylie W. ; Nemeroff, Charles. / Growth hormone response to growth hormone-releasing factor in depression. In: Peptides. 1988 ; Vol. 9, No. SUPPL. 1. pp. 113-116.
@article{7ea210ff225f45d29184f4f97d79dfa1,
title = "Growth hormone response to growth hormone-releasing factor in depression",
abstract = "A blunted growth hormone (GH) response to clonidine and other pharmacologic stimuli has been reported in patients with depression. This blunted growth hormone response to clonidine had led to the speculation that there is a central alpha-2 adrenergic receptor subsensitivity in depression. This hypothesis is based on the assumption that the pituitary somatotroph response to growth hormone-releasing factor (GHRF) is not altered in depression. In the present preliminary study, the somatotroph response to GHRF in depressed patients and normal controls has been evaluated in four depressed patients and four age- and sex-matched controls. The GH response to GRF is highly variable both in normal individuals and in the depressed patients studied. Larger numbers of patients and controls must be studied before any definitive conclusions can be drawn about GH responses to GRF in depressed patients.",
keywords = "Depression, Growth hormone (GH), Growth hormone-releasing factor (GHRF)",
author = "Krishnan, {K. Ranga R} and Manepalli, {Ananth N.} and Ritchie, {James C.} and Krishniah Rayasam and Melville, {Mary Lou} and Thorner, {Michael O.} and Rivier, {Jean E.} and Vale, {Wylie W.} and Charles Nemeroff",
year = "1988",
month = "1",
day = "1",
doi = "10.1016/0196-9781(88)90234-3",
language = "English",
volume = "9",
pages = "113--116",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Growth hormone response to growth hormone-releasing factor in depression

AU - Krishnan, K. Ranga R

AU - Manepalli, Ananth N.

AU - Ritchie, James C.

AU - Rayasam, Krishniah

AU - Melville, Mary Lou

AU - Thorner, Michael O.

AU - Rivier, Jean E.

AU - Vale, Wylie W.

AU - Nemeroff, Charles

PY - 1988/1/1

Y1 - 1988/1/1

N2 - A blunted growth hormone (GH) response to clonidine and other pharmacologic stimuli has been reported in patients with depression. This blunted growth hormone response to clonidine had led to the speculation that there is a central alpha-2 adrenergic receptor subsensitivity in depression. This hypothesis is based on the assumption that the pituitary somatotroph response to growth hormone-releasing factor (GHRF) is not altered in depression. In the present preliminary study, the somatotroph response to GHRF in depressed patients and normal controls has been evaluated in four depressed patients and four age- and sex-matched controls. The GH response to GRF is highly variable both in normal individuals and in the depressed patients studied. Larger numbers of patients and controls must be studied before any definitive conclusions can be drawn about GH responses to GRF in depressed patients.

AB - A blunted growth hormone (GH) response to clonidine and other pharmacologic stimuli has been reported in patients with depression. This blunted growth hormone response to clonidine had led to the speculation that there is a central alpha-2 adrenergic receptor subsensitivity in depression. This hypothesis is based on the assumption that the pituitary somatotroph response to growth hormone-releasing factor (GHRF) is not altered in depression. In the present preliminary study, the somatotroph response to GHRF in depressed patients and normal controls has been evaluated in four depressed patients and four age- and sex-matched controls. The GH response to GRF is highly variable both in normal individuals and in the depressed patients studied. Larger numbers of patients and controls must be studied before any definitive conclusions can be drawn about GH responses to GRF in depressed patients.

KW - Depression

KW - Growth hormone (GH)

KW - Growth hormone-releasing factor (GHRF)

UR - http://www.scopus.com/inward/record.url?scp=0024166710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024166710&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(88)90234-3

DO - 10.1016/0196-9781(88)90234-3

M3 - Article

C2 - 2856637

AN - SCOPUS:0024166710

VL - 9

SP - 113

EP - 116

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - SUPPL. 1

ER -